Teva, US Argue Over Drug Definitions in Medicare Price Cut Suit

A federal appeals court judge appeared skeptical Tuesday of a lawsuit from Teva Pharmaceuticals Inc. challenging the US government’s standard for selecting medicines for a Medicare drug price negotiation program.

“If you look at the entire intent of this, what they’re trying to do is figure out what are the most expensive drugs,” said Judge Florence Pan of the US Court of Appeals for the District of Columbia Circuit. “They want to go across different dosages and formulations.”

The argument before Pan and two other judges comes after a lower court ruled last year that Teva’s challenge against the Centers ...